• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, January 8, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Chemistry

GPs need training to tackle chronic opioid use

Bioengineer by Bioengineer
May 13, 2019
in Chemistry
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

GPs must be better-equipped to support patients to manage the psychological challenge of reducing their opioid use – according to new research from the University of East Anglia.

The recommendation is part of a toolkit being launched today to help GPs reduce the amount of opioids they prescribe.

The toolkit outlines seven areas of best practice to tackle chronic opioid use – based on international research evidence, the experiences of health organisations and individual practitioners.

It comes after figures for England and Wales revealed an increase in opioid prescriptions of more than 60 per cent over the last decade – from 14 million in 2008 to 23 million last year.

Lead researcher Dr Debi Bhattacharya, from UEA’s School of Pharmacy, said: “Opioids, like morphine, tramadol and fentanyl, can be effective for the short-term management of severe pain. However, they are highly addictive which makes stopping difficult yet long-term use can impair quality of life and overuse can be deadly.”

“GPs and other health professionals need to urgently, proactively work with patients prescribed long-term opioids for non-cancer pain to gradually reduce or ‘taper’ their doses.

“But if GPs are expected to initiate discussions about tapering or stopping opioids, they must be equipped with training to manage the psychological challenges experienced by patients when trying to reduce their opioid use.”

“Without this training, prescribers are reticent to open ‘a can of worms’ that they know they don’t have the skills to manage.”

“For opioid tapering interventions to be effective, GPs need training in giving their patients the skills to manage any withdrawal effects.”

Dr Bhattacharya said: “There needs to be a clear expectation that opioid de-prescribing is the responsibility of the prescriber.

“Incentives may help GPs and other health professionals to prioritise reducing the amount of opioids being prescribed to patients, particularly among those who have been taking them long-term.

“Prescribers need to better understand the consequences of excess opioid use, and they need better guidelines about how to gradually reduce or ‘taper’ doses.”

###

The ‘Toolkit for Tackling Chronic Opioid Use in Non-Cancer Pain’ launches on Monday May 13, and is available at http://www.uea.ac.uk/pharmacy/research/chronic-opioid-use-in-non-cancer-pain/toolkit . It has been supported by NIHR Collaboration for Leadership in Applied Health Research and Care East of England, hosted by Cambridgeshire and Peterborough NHS Foundation Trust. For more information about the project visit http://www.uea.ac.uk/pharmacy/research/chronic-opioid-use-in-non-cancer-pain

Media Contact
Communications Office
[email protected]

Tags: AddictionHealth Care Systems/ServicesHealth ProfessionalsMedicine/HealthPainPharmaceutical ChemistryPharmaceutical ScienceSocial/Behavioral Science
Share12Tweet8Share2ShareShareShare2

Related Posts

Biocompatible Ligand Enables Safe In-Cell Protein Arylation

Biocompatible Ligand Enables Safe In-Cell Protein Arylation

January 8, 2026
Monovalent Pseudo-Natural Products Boost IDO1 Degradation

Monovalent Pseudo-Natural Products Boost IDO1 Degradation

January 7, 2026

Catalytic Enantioselective [1,2]-Wittig Rearrangement Breakthrough

January 7, 2026

Stereoselective Total Synthesis of Skew-Tetramantane Achieved

January 6, 2026
Please login to join discussion

POPULAR NEWS

  • Enhancing Spiritual Care Education in Nursing Programs

    153 shares
    Share 61 Tweet 38
  • PTSD, Depression, Anxiety in Childhood Cancer Survivors, Parents

    143 shares
    Share 57 Tweet 36
  • Impact of Vegan Diet and Resistance Exercise on Muscle Volume

    46 shares
    Share 18 Tweet 12
  • SARS-CoV-2 Subvariants Affect Outcomes in Elderly Hip Fractures

    44 shares
    Share 18 Tweet 11

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Author Correction: Are Oysters Truly Sustainable Bluefood?

Neuro-Epithelial Circuits Boost Gut Immunity

Superradiant Terahertz Laser Powered by Electron Microbunches

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 71 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.